Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse.

Nature biotechnology·2026
Same author

Botryolides F and G from the Fungus <i>Bartalinia robillardoides</i> with Anthelmintic Activity.

Journal of natural products·2026
Same author

Seven subsets, two fates: mouse γδ T cells in cancer immunity.

Trends in immunology·2026
Same author

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Cell reports·2026
Same author

Live-cell 3D-SIM of Rift Valley fever virus NSs filaments reveals a polygon web architecture.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.

Science advances·2026

Related Experiment Video

Updated: Nov 12, 2025

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.2K

Neutrophil dynamics in the tumor microenvironment.

Amanda J McFarlane1, Frédéric Fercoq1, Seth B Coffelt1,2

  • 1Cancer Research UK Beatson Institute, Glasgow, United Kingdom.

The Journal of Clinical Investigation
|March 15, 2021
PubMed
Summary

Neutrophils, once thought static, are now understood to be dynamic immune cells within the tumor microenvironment. Recent technological advances reveal their critical roles, offering new therapeutic targets for cancer treatment.

More Related Videos

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.6K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.2K

Related Experiment Videos

Last Updated: Nov 12, 2025

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.2K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.6K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.2K

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The tumor microenvironment (TME) significantly impacts immune cell behavior and function.
  • Immune cells exhibit plasticity, interacting dynamically with tumor cells and stroma to influence disease progression.
  • Neutrophils were historically underestimated due to challenges in in vitro study.

Purpose of the Study:

  • To discuss recent findings on neutrophil roles within the TME.
  • To highlight how technological advancements are reshaping our understanding of neutrophils.
  • To explore novel strategies for targeting neutrophils in cancer therapy.

Main Methods:

  • Review of recent data from advanced neutrophil research tools.
  • Analysis of in-context studies of neutrophils within the TME.
  • Synthesis of current knowledge on neutrophil plasticity and function.

Main Results:

  • Technological progress has enabled a clearer view of neutrophil behavior in the TME.
  • Neutrophils are revealed to be dynamic and influential immune players.
  • Understanding neutrophil plasticity is key to their role in cancer.

Conclusions:

  • Neutrophils are critical, adaptable components of the tumor immune landscape.
  • New insights necessitate a re-evaluation of neutrophil function in cancer.
  • Targeting neutrophils presents a promising avenue for novel cancer therapeutics.